Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,868 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-A Blood Type Is a Risk Factor for Poor Cardio-Cerebrovascular Outcomes in Patients Undergoing Dialysis.
Nakayama T, Yamamoto J, Ozeki T, Tsuruta Y, Yokoi M, Aoi T, Mori Y, Hori M, Tsujita M, Shirasawa Y, Kondo C, Yasuda K, Murata M, Kinoshita Y, Suzuki S, Fukuda M, Yamazaki C, Ikehara N, Sugiura M, Goto T, Hashimoto H, Yajima K, Maruyama S, Morozumi K, Seo Y. Nakayama T, et al. Among authors: mori y. Biomedicines. 2023 Feb 16;11(2):592. doi: 10.3390/biomedicines11020592. Biomedicines. 2023. PMID: 36831128 Free PMC article.
Impact of an angulated aorto-septal relationship on cardio-cerebrovascular outcomes in patients undergoing hemodialysis.
Nakayama T, Yamamoto J, Ozeki T, Tokoroyama S, Mori Y, Hori M, Tsujita M, Shirasawa Y, Takeda A, Kondo C, Murata M, Suzuki S, Kinoshita Y, Fukuda M, Ueki T, Ikehara N, Sugiura M, Goto T, Hashimoto H, Yajima K, Maruyama S, Koyama H, Morozumi K, Seo Y. Nakayama T, et al. Among authors: mori y. PLoS One. 2024 Feb 23;19(2):e0298637. doi: 10.1371/journal.pone.0298637. eCollection 2024. PLoS One. 2024. PMID: 38394305 Free PMC article.
CLINICAL AND VIROLOGICAL STUDIES ON HAKURI (SAKAMOTO).
SAKAMOTO A, SUZUKI S, FURUKAWA T, MORI Y, KONDO K. SAKAMOTO A, et al. Among authors: mori y. Acta Paediatr Jpn. 1963 Jun;68:5-10. Acta Paediatr Jpn. 1963. PMID: 14204482 No abstract available.
Phase 3 Study of Talazoparib Plus Enzalutamide Versus Placebo Plus Enzalutamide as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: TALAPRO-2 Japanese Subgroup Analysis.
Matsubara N, Miyake H, Uemura H, Mizokami A, Kikukawa H, Kosaka T, Nishimura K, Nakamura M, Kobayashi K, Komaru A, Mori Y, Toyoizumi S, Hori N, Umeyama Y, Uemura H. Matsubara N, et al. Among authors: mori y. Cancer Med. 2025 Jan;14(1):e70333. doi: 10.1002/cam4.70333. Cancer Med. 2025. PMID: 39737542 Free PMC article. Clinical Trial.
TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation.
Sakoda T, Kikushige Y, Irifune H, Kawano G, Harada T, Semba Y, Hayashi M, Shima T, Mori Y, Eto T, Kamimura T, Iwasaki H, Ogawa R, Yoshimoto G, Kato K, Maeda T, Miyamoto T, Akashi K. Sakoda T, et al. Among authors: mori y. Cancer Sci. 2024 Dec 26. doi: 10.1111/cas.16431. Online ahead of print. Cancer Sci. 2024. PMID: 39726280 Free article.
5,868 results